N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Oil Pulling Reduction

Sponsor: The University of Texas Health Science Center at San Antonio • ClinicalTrials.gov ID: NCT07706647

Registry updated: 2026-08-24
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The goal of this study is to scientifically evaluate the efficacy of this oil pulling oral rinse in reducing dental plaque, gingival inflammation, gingival bleeding, and selectively reducing caries- and periodontal disease-associated bacteria compared to a marketed mouthwash and a placebo oral rinse

Interventions

  • GuruNanda natural Oil Pulling oral rinse (Dietary supplement)
    test product
  • TheraBreath Plaque Control Oral Rinse (Dietary supplement)
    negative control
  • GuruNanda water-based non-whitening mouthwash (Dietary supplement)
    negative control

Eligibility criteria

Inclusion Criteria: 1. Adult subjects aged 18-70, that are in good health. 2. Subject must have: 1. Baseline gingival inflammation (MGI) score of at least 1.80. 2. Baseline gingival bleeding (GBI) score of ≥ 1 on at least 20 sites. 3. An overnight (12 to 18 hour abstention from any oral hygiene) dental plaque (mean) score greater than 0.6 according to the RMNPI Index. 4. Have a minimum of 20 'scorable' teeth (excluding 3rd molars). 5. The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form. 6. The subjects should be willing to comply with the study procedure and schedule, including the follow-up visits. Exclusion Criteria: 1. Current or history of oral cavity cancer or oropharyngeal cancer. 2. Subject with destructive periodontal disease or those on antibiotic or anti-inflammatory drugs. 3. Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body. 4. Pregnant or nursing by subject report. 5. Known allergic reaction to any of the study mouthwashes or any of their component. 6. Any active condition, including but not limited to advanced periodontal disease or severe gingival recession, in the oral cavity at the discretion of the investigator. 7. Any surgery or recent dental procedure in the oral cavity within 3 months prior to treatment, or before complete healing. 8. Subjects that do not brush regularly. 9. Any condition that might make it unsafe for the subject to participate in this study, at the discretion of the investigator. 10. History of allergy or hypersensitivity to mouthwash ingredients 11. Significant medical conditions, such as uncontrolled diabetes or immunosuppressive disorders 12. Use of tobacco products, including cigarettes and smokeless tobacco 13. Presence of orthodontic appliances, except for removable retainers 14. Participation in another clinical trial within the last 30 days. 15. Individuals unable to comply with study requirements, such as regular product use or scheduled visits. 16. Habitual use of alcohol or drugs that may affect compliance or oral health

Conditions

Good Health Gingival Inflammation and Bleeding Dental Plaque

Locations

  • Clinical Research Facility of the Center for Oral Health and Research, UTHSA — San Antonio, Texas, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record